Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001866265 | SCV002315806 | likely pathogenic | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-10-19 | criteria provided, single submitter | clinical testing | This variant is also known as c.78936C>A, p.Tyr26312*. This premature translational stop signal has been observed in individual(s) with clinical features of TTN-related conditions (PMID: 30847666, 31737537). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr28880*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Clinical Genetics, |
RCV001700868 | SCV001918361 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001700868 | SCV001927495 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001700868 | SCV001953574 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |